AMGEN INC
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
| Item 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
|---|
During the three months ended September 30, 2025, we had one outstanding stock repurchase program, under which we had no repurchase activity.
| Period · Total numberof sharespurchased · Averageprice paidper share · Total numberof shares purchasedas part of publicly announced program · Maximum dollarvalue that mayyet be purchasedunder the program | ||||||||
|---|---|---|---|---|---|---|---|---|
| July 1–31 | — | — | — | $6,779,253,902 | ||||
| August 1–31 | (1) | (1) | — | $6,779,253,902 | ||||
| September 1–30 | — | — | — | $6,779,253,902 | ||||
| Total | — | — | ||||||
(1)In August 2025, the Company purchased 1,700 shares at an average price paid of $284.67 per share from a staff member to satisfy federal law compliance obligations. These shares were not repurchased under our stock repurchase program.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.